Lucas Trevor, Abraham Dietmar, Aharinejad Seyedhossein
Laboratory for Cardiovascular Research, Center for Anatomy and Cell Biology, Vienna Medical University, Waehringer strasse 13, Vienna, A-1090, Austria.
Front Biosci. 2008 May 1;13:5580-8. doi: 10.2741/3101.
It is becoming increasingly clear that interactions between cancer cells, stroma cells and the extracellular matrix (ECM) are pivotal to the processes of neovascularization and tumorigenesis. As tumor stromal components known as tumor associated macrophages (TAMs), mononuclear phagocytes can play a key role in tumor type specific neoangiogenesis by promoting remodeling of the ECM through the production of matrix metalloproteases (MMPs), secreting pro-angiogenic growth factors and stabilizing the tumor vasculature. The growth factor colony-stimulating factor-1 is produced by a wide variety of cancer cells and tumor stroma cells and influences the migration, survival and phenotype of TAMs. Thus, understanding the relationships of the cancer cell with the host environment is key for specifically exploiting tumor growth promoting tumor host interactions for new therapeutic strategies. This review outlines the strategies for targeting CSF-1 in malignancies to influence TAMs in tumor development.
越来越明显的是,癌细胞、基质细胞与细胞外基质(ECM)之间的相互作用对于新血管形成和肿瘤发生过程至关重要。作为被称为肿瘤相关巨噬细胞(TAM)的肿瘤基质成分,单核吞噬细胞可通过产生基质金属蛋白酶(MMP)促进ECM重塑、分泌促血管生成生长因子以及稳定肿瘤脉管系统,在肿瘤类型特异性新生血管形成中发挥关键作用。生长因子集落刺激因子-1由多种癌细胞和肿瘤基质细胞产生,并影响TAM的迁移、存活和表型。因此对于新的治疗策略而言,了解癌细胞与宿主环境之间的关系是特异性利用促进肿瘤生长的肿瘤-宿主相互作用的关键。本综述概述了在恶性肿瘤中靶向CSF-1以影响肿瘤发展中TAM的策略。